Wall Street Zen upgraded shares of Addus HomeCare (NASDAQ:ADUS – Free Report) from a buy rating to a strong-buy rating in a report released on Monday morning.
ADUS has been the subject of a number of other research reports. Barclays raised their price objective on Addus HomeCare from $111.00 to $117.00 and gave the company an “underweight” rating in a research note on Tuesday, November 4th. Weiss Ratings reissued a “hold (c+)” rating on shares of Addus HomeCare in a research report on Wednesday, January 21st. Royal Bank Of Canada boosted their price target on shares of Addus HomeCare from $134.00 to $139.00 and gave the company an “outperform” rating in a research note on Friday, November 7th. Truist Financial set a $135.00 price objective on shares of Addus HomeCare and gave the company a “buy” rating in a research note on Wednesday, January 7th. Finally, TD Cowen reiterated a “buy” rating on shares of Addus HomeCare in a report on Wednesday, November 5th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Addus HomeCare presently has a consensus rating of “Moderate Buy” and an average price target of $135.44.
Read Our Latest Stock Report on ADUS
Addus HomeCare Stock Performance
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Royal Bank of Canada grew its position in Addus HomeCare by 24.3% in the 1st quarter. Royal Bank of Canada now owns 6,899 shares of the company’s stock worth $682,000 after purchasing an additional 1,347 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Addus HomeCare by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,374 shares of the company’s stock worth $1,026,000 after buying an additional 459 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of Addus HomeCare by 6.1% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 51,679 shares of the company’s stock worth $5,111,000 after buying an additional 2,952 shares during the last quarter. Jane Street Group LLC grew its holdings in shares of Addus HomeCare by 387.6% in the first quarter. Jane Street Group LLC now owns 11,045 shares of the company’s stock valued at $1,092,000 after acquiring an additional 8,780 shares in the last quarter. Finally, Intech Investment Management LLC increased its position in shares of Addus HomeCare by 44.7% during the first quarter. Intech Investment Management LLC now owns 14,362 shares of the company’s stock valued at $1,420,000 after acquiring an additional 4,439 shares during the last quarter. 95.35% of the stock is currently owned by hedge funds and other institutional investors.
Key Headlines Impacting Addus HomeCare
Here are the key news stories impacting Addus HomeCare this week:
- Positive Sentiment: Q4 results showed strong top‑line growth — service revenues rose ~25.6% year‑over‑year to roughly $372–373M, reflecting sustained demand for home‑based care and organic/acquired growth. Addus HomeCare Announces Fourth Quarter and Year End 2025 Financial Results
- Positive Sentiment: Adjusted earnings per share beat consensus — management reported adjusted net income per diluted share of $1.77 (vs. Street ~ $1.71), which market reports cite as the main earnings beat driving optimism. View Press Release
- Positive Sentiment: Operating leverage and profitability improved — adjusted EBITDA and operating margins expanded (adjusted EBITDA +33.3% y/y), suggesting scalable economics as revenue grows. Addus HomeCare Announces Fourth Quarter and Year End 2025 Financial Results
- Positive Sentiment: Analyst sentiment and upgrades support the rally — recent upgrades/Buy/Strong‑Buy notes and price targets above the current level (median targets near ~$139–140) amplify upside expectations. Addus HomeCare (NASDAQ:ADUS) Upgraded to Strong-Buy at Wall Street Zen
- Neutral Sentiment: Mixed GAAP vs. adjusted figures — some outlets report GAAP diluted EPS of $1.61 (vs. adjusted $1.77) and small differences in revenue figures depending on the source; investors should watch reconciliations in the company release. Addus HomeCare Corporation (ADUS) Releases Q4 2025 Earnings: Strong Revenue Growth but EPS Miss
- Neutral Sentiment: Cash flow and balance‑sheet items are mixed — operating cash improved y/y, but cash balances declined versus prior year; monitor free cash flow and capex trends in upcoming quarters. Addus HomeCare Corporation (ADUS) Releases Q4 2025 Earnings: Strong Revenue Growth but EPS Miss
- Negative Sentiment: Some third‑party tallies show slight misses vs. certain Wall Street estimates (Quiver noted revenue and diluted EPS marginally below particular consensus figures), which could temper expectations if future quarters repeat the pattern. Addus HomeCare Corporation (ADUS) Releases Q4 2025 Earnings: Strong Revenue Growth but EPS Miss
- Negative Sentiment: Insider selling activity has been recorded in recent months (several sales by senior executives), which some investors view as a cautionary signal. Addus HomeCare Corporation (ADUS) Releases Q4 2025 Earnings: Strong Revenue Growth but EPS Miss
Addus HomeCare Company Profile
Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.
The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.
Recommended Stories
- Five stocks we like better than Addus HomeCare
- Elon Musk already made me a “wealthy man”
- Elon’s Secret AI Partner?
- Elon Musk: This Could Turn $100 into $100,000
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- REVEALED: Something Big Happening Behind White House Doors
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
